Chromosome Analysis, Multiple Myeloma Panel by FISH
Navigation Links
Chromosome Analysis, Multiple Myeloma Panel by FISH
| Products | Chromosome Analysis, Multiple Myeloma Panel by FISH |
| Company | ARUP Laboratories |
| Item | Chromosome Analysis, Multiple Myeloma Panel by FISH |
| Features | |
| Description | ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics. |
| Info | ARUP Laboratories Customer Service: (800) 522-2787 Web site: http://www.aruplab.com |
Related medicine products :
1. Chromosome Analysis, Amniotic Fluid
2. Chromosome Analysis, Bone Marrow
3. Chromosome Analysis, Chorionic Villus Sampling (CVS)
4. Chromosome Analysis, Breakage Syndrome Analysis
5. Chromosome Analysis, Fetal Blood
6. Chromosome Analysis, Chronic Lymphocytic Leukemia (CLL) Panel by FISH
7. Chromosome Analysis, FISH-Interphase
8. Chromosome Analysis, High Resolution (Prometaphase Study)
9. Chromosome Analysis, FISH-Metaphase
10. Chromosome Analysis, Oncology
11. Chromosome Analysis, Leukemic Blood
Breaking Medicine News(10 mins):Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 2Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 3Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 4Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 2Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 3Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 4Health News:Zogenix Increases Series B Preferred Stock Financing to $71 Million, Raising $35 Million in Second Tranche 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 3
[0] New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V)[0] Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma[0] Social Networking Community Reaches Out to Persons With Illnesses and Disabilities [0] Zogenix Increases Series B Preferred Stock Financing to $71 Million, Raising $35 Million in Second Tranche[0] New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director
Other Medicine News:Health News:Twenty-Five Individuals Honored by Yoplait(R) for Making Extraordinary Strides in the Fight Against Breast Cancer 2Health News:Twenty-Five Individuals Honored by Yoplait(R) for Making Extraordinary Strides in the Fight Against Breast Cancer 3Health News:Twenty-Five Individuals Honored by Yoplait(R) for Making Extraordinary Strides in the Fight Against Breast Cancer 4Health News:More States Move to Require Hospitals to Screen Patients for MRSA 2Health News:More States Move to Require Hospitals to Screen Patients for MRSA 3Health News:More States Move to Require Hospitals to Screen Patients for MRSA 4Health News:Global Cervical Artificial Disc Market to Hit $1 Billion by 2012 2Health News:Intercim Launches Pertinence Suite Powered by Velocity 2Health News:Intercim Launches Pertinence Suite Powered by Velocity 3Health News:Intercim Launches Pertinence Suite Powered by Velocity 4Health News:MedAptus Experiences Record Growth of 70 Percent 2Health News:MedAptus Experiences Record Growth of 70 Percent 3
Twenty-Five Individuals Honored by Yoplait(R) for Making Extraordinary Strides in the Fight Against Breast CancerMore States Move to Require Hospitals to Screen Patients for MRSACompetitive Intelligence: Information Collection TacticsGlobal Cervical Artificial Disc Market to Hit $1 Billion by 2012Intercim Launches Pertinence Suite Powered by VelocityMedAptus Experiences Record Growth of 70 Percent
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 1Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 2Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 3Say Cheese With Milk 47498 1Say Cheese With Milk 47498 2Say Cheese With Milk 47498 3Say Cheese With Milk 47498 4Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 1Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 2Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |